BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
BlueRock offers the opportunity to work with an incredible team of tallented and exceptionally knowledgeable scientists and leaders in the field.
Quelle est la meilleure partie de votre programme de rémunération?
The majority is not tied to company performance.
Quelles sont les meilleures choses à propos de votre équipe?
The team is collaborative and open to alternative viewpoints.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
BlueRock provide the positive culture and environment that fosters collaboration.
Qu’est-ce qui vous rend le plus heureux au travail?
Interacting with my colleagues. The opportunity to make a difference.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
They are proactive not reactive in providing leadership. Establishing the Leadership Team to involve more members of the BlueRock team in decisions regarding the operation and future of the company is one example..
Other Employee Reviews for BlueRock Therapeutics
×